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Abstract. GRA4 of Toxoplasma gondii has been shown to prompt IgG, IgM and IgA
responses in previous studies and is thus considered one of the major immunogenic
proteins from T. gondii that can be used for both diagnostics purposes and vaccine
development. This study seeks to clone and express the GRA4 in Pichia pastoris, which
has numerous advantages over other systems for expression of eukaryotic proteins. In
order to achieve this, the gene was cloned into the pPICZα A expression vector, which
was then incorporated into the P. pastoris genome via insertional integration for
expression of the recombinant protein, under the AOX1 promoter. The antigen was
expressed along with the prepro sequence of the α-factor of yeast so that it could be
excreted out of the P. pastoris cells and obtained from the medium. Upon SDS-PAGE
analysis it was found that the recombinant protein was expressed optimally as a 40 kDa
protein after 96 hours of induction with 0.75% of methanol. The expressed GRA4 protein
showed discrepancy in size with the calculated molecular mass. This may be attributed
to the various posttranslational modifications including glycosylation and phosphorylation.
Despite the difference in molecular weight, the recombinant protein was able to detect
toxoplasmosis in Western blot format. The recombinant GRA4 was expressed with an
intact polyhistidine-tag, which could be used for future purification of the antigen.
INTRODUCTION
Toxoplasmosis is a parasitic disease
caused by the apicomplexan parasite
Toxoplasma gondii, which can infect a
very wide range of intermediate hosts,
including all warm-blooded animals and
birds, but the primary host is the Felidae
family (domestic or wild cats). It is
estimated that up to 50% of the world’s
human population is infected by the
disease (Cesbron-Delauw, 1994). An
immunocompetent individual may present
no symptoms for the disease or mild flu-like
symptom during the first few weeks.
However, in immunocompromised patients,
such as those with AIDS, cancer, neoplastic
disease, or transplant recipients, the
disease can cause chorioretinitis,
encephalitis and neurological diseases,
often proving to be fatal (Mévélec et al.,
1992; Suzuki & Remington, 1993). Toxo-
plasmosis contracted during pregnancy can
lead to abortion, stillbirth or neonatal
malformations. The infection is not limited
to humans and affects the agricultural
industry worldwide causing abortion in
sheep and goats (Mévélec et al., 1992).
Current diagnostic tests against
infection are difficult, expensive and
sometimes non-specific because the kits
employ total cellular lysate antigen
(Hofgartner et al., 1997; Wilson et al.,
1997). Moreover the methods and source of
antigens involve the usage of parasite
culture which can prove to be hazardous to
laboratory staff handling the samples.
Usage of recombinant protein cloned and
expressed in suitable expression systems
is a potential alternative source of antigens.
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For this purpose, several antigens have
been identified in the parasite that can
bring about induction of the host’s immune
system. Most of these proteins are specific
to a certain stage of the parasite’s life
cycle, while some are common to various
stages of the life cycle.
Surface antigens (SAGs) are the most
comprehensively studied proteins,
including SAG1 and SAG2 protein families
and their relatives. SAG1 has been the
most researched of all vaccine candidates
for toxoplasmosis (Shang et al., 2009).
Beside SAGs, there are three secretory
organelles which produce three distinct
proteins of immunogenic importance.
These are microneme proteins (MICs),
rhoptry proteins (ROPs) and dense
granular proteins (GRAs) (Smith, 1995).
Amongst this is the GRA4 protein, which is
involved in nutrition acquirement and
trafficking of proteins between the host and
the parasite. Escherichia coli derived
recombinant GRA4 has been shown to
prompt IgG, IgM and IgA responses in
previous studies and is thus considered one
of the major immunogenic proteins from T.
gondii that can be used for both diagnostics
purposes and vaccine development
(Mévélec et al., 1992; Martin et al., 2004;
Zhang et al., 2007; Ferraro et al., 2008).
Immunization with GRA4 expressing
plasmids were shown to give protection to
mice against lethal challenges with T.
gondii by inducing a Th1-type response
and releasing IL-2 and large amounts of
IFN-γ (Desolme et al., 2000). Moreover,
mice vaccinated with GRA4 expressing
plasmids induced protective immunity
against acute infection by lethal challenge
with tissue cysts (Desolme et al., 2000).
However, it is known that recombinant
protein produced in E. coli often looses its
antigenic value due to an incorrect folding
(Meek et al., 2003). Thus, this study seeks
to clone and express the GRA4 gene in
Pichia pastoris, which has numerous
advantages over other systems for
expression of eukaryotic proteins. The
Pichia expression system possesses all the
post-translational mechanisms which
produce recombinant proteins having
conformation that is almost similar to the
native proteins (Cregg et al., 1993). This
yeast has a very high growth rate and
expression rate of recombinant proteins,
yielding up to 12 g/L of fermentation culture
in the case of recombinant tetanus toxin
fragment C production (Clare et al., 1991).
On the other hand, unlike other eukaryote
expression systems, this yeast does not
require expensive growth media such as
fetal bovine serum. In fact it is capable of
growing using methanol as its sole carbon
source (Cregg et al., 1993; Kalidas, 2004).
This yeast does not produce large amounts
of native proteins, so purifying the
recombinant protein from the total protein
is easy and inexpensive (Kalidas, 2004).
The Pichia expression system has
successfully been used to produce
numerous of T. gondii recombinant




Tachyzoites of the T. gondii RH strain were
obtained from the Institute for Medical
Research Kuala Lumpur, Malaysia. The
tachyzoites were grown in MBDK cell
monolayers in RPMI supplemented with
10% fetal calf serum at 37ºC in a 5% CO2
environment.
PCR amplification of GRA4 gene
The T. gondii tachyzoite genome was used
as the template for the initial PCR, to
amplify the GRA4 gene using specific
primers: 5’ GCTGAATTCACCATGCAGGG
CACTTGGTT 3’ and 5’ GCTGAATTCCGCT
CTTTGCGCATTCTTTCC 3’. These primers
were designed based on published
sequence (GenBank accession number:
M76432.1). EcoRI (Fermentas Life
Sciences, Canada) cutting site (GAATTC)
was incorporated into the primers to
facilitate splicing of the PCR fragment into
the corresponding EcoRI site of the
expression plasmid vector, pPICZα A
(Invitrogen Corp., USA). PCR was carried
out in a 25 µl reaction mixture containing
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1 U Taq DNA polymerase (Fermentas Life
Sciences, Canada). The PCR mixture was
initially pre-heated at 95ºC for 10 min for
initial denaturation before 30 cycles of
amplification, which consisted of
denaturation at 94ºC for 1 min, annealing
at 54ºC for 1 min, and elongation at 72ºC
for 2 min. Final extension of the reaction
was carried out at 72ºC for 10 min.
Recombinant plasmid construction
The amplified DNA fragment was
digested with EcoRI and spliced into the
corresponding cloning site in pPICZα A.
The recombinant vectors were transformed
into E. coli TOP10F ’. This bacterial strain
was grown in either Luria Bertani broth or
on Luria Bertani agar, supplemented with
zeocin (50 µg/ml, Invitrogen Corp., USA).
Positive recombinant clones were selected
and their plasmids were extracted and sent
to a commercial laboratory for sequencing
to confirm the orientation and integrity of
the GRA4 gene.
Transformation and expression of
recombinant GRA4 in P. pastoris
Transformation of P. pastoris with the
recombinant pPICZα A was done according
to the manufacturer’s protocol of the
EasySelectTM Pichia Expression kit
(Invitrogen Corp., USA). Positive
recombinant P. pastoris clones were
selected for expression study. A single
recombinant P. pastoris colony was
inoculated into 25 ml of buffered complex
medium containing glycerol. The culture
was grown at 28ºC for 24 h. The cells were
harvested and resuspended in 100 ml of
buffered complex medium containing
methanol. The culture was allowed to grow
for 72 h. Methanol was added every 24 h to
a final concentration of 0.5% to induce
expression of the recombinant GRA4 gene.
Pichia pastoris cells culture was collected
every 12 h after methanol induction for
protein extraction and analysis. Non-
recombinant P. pastoris host cells (X-33
strain) and X-33 transformed with parent
vector (without insert) were similarly
treated and analyzed as negative controls.
The growth conditions in shake flasks such
as methanol concentration and inducing
time were optimized.
Protein precipitation
The recombinant P. pastoris cells were
removed from the growth medium by
pelleting at low speed centrifugation. An
equal volume of 20% (v/v) trichloroacetic
acid was added to the growth medium. The
mixture was incubated on ice for 1 h or
overnight at -20ºC. The mixture was then
centrifuged at 12,000g for 30 min to harvest
the protein precipitate. The pellet was then
washed with acetone, and centrifuged at
12,000g for 5 min, followed by air drying at
room temperature for 10 min. The protein
was resuspended in phosphate-buffered
saline (PBS).
SDS-PAGE and Western blot
The recombinant proteins were evaluated
in Western blot assays using sera of
patients diagnosed with toxoplasmosis (n =
20) and healthy donors (n = 20). Specificity
of the recombinant protein was also tested
with sera of patients diagnosed as having
amebiasis (1 samples), cysticercosis (3
samples), filariasis (2 samples), malaria (3
samples), and toxocariasis (1 samples).
These samples were obtained from the
Diagnostic Laboratory at the Department of
Parasitology, University of Malaya. The
harvested proteins were separated by SDS-
PAGE and transferred by electroblotting to
polyvinylidene difluoride membranes (Bio-
Rad, USA). The proteins were probed with
human serum (at 1:200 dilution) or anti-His
antibody (Invitrogen, USA) (at dilution
1:1000). Bound antibodies were detected
with alkaline phosphatase-conjugated goat
anti-human IgM/IgG (Bio-Rad, USA) or goat
anti-mouse IgG and IgM (KPL, USA),
respectively.
RESULTS
Cloning and expression of T. gondii
GRA4 in P. pastoris
GRA4 protein was extracellularly
expressed in yeast and obtained from the
culture medium by TCA precipitation. Two
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negative controls were included in the
expression study, one is P. pastoris cells
alone, and another one is cells transformed
with pPICZα A vector without the GRA4
insert. These two samples provided the
background native proteins that the yeast
generally expressed and the proteins that
were encoded by the vector in absence of
the insert of interest. A sample was also
collected from the recombinant clone
culture at 0 hours to observe the bands
representing proteins right before
induction. SDS-PAGE analysis through a
12% resolving gel showed the appearance
of a novel band at approximately 40 kDa
upon coomassie staining, which was absent
in the negative controls. This size
corresponds to the predicted molecular
weight of recombinant GRA4, together with
the polyhistidine-tag (Figure 1).
Optimization of the expression condition
for production of recombinant antigen
Qualitative analysis of the intensity of the
bands at different hours showed that it had
the highest intensity for the 96 hour sample.
This was thus deemed as the optimum time
of expression and thereafter samples were
only analyzed for this time interval. The
expression of the GRA4 protein was induced
under 5 different methanol concentrations:
0.25%, 0.5%, 0.75%, 1% and 1.5%. A band was
present for each of the 5 lanes at
approximately 40 kDa (Figure 2). However,
as the concentration of methanol was
increased, the band appeared to become
more intense, until a peak was reached at
0.75% of mathanol concentration. After this
concentration, the intensity of the band was
observed to decrease.
Western blot analysis on the expression
of recombinant GRA4 in P. pastoris
The antigenicity of the recombinant GRA4
was tested by Western blot using a positive
human serum. When total recombinant
proteins were analyzed with serum of a
toxoplasmosis patient, non-specific bands
were seen in all lanes including the
negative controls (Figure 3). A novel 40
kDa protein was observed in the lanes
containing the proteins from recombinant
GRA4 clone (Figure 3). The recombinant
protein was further evaluated by Western
blot using 20 Toxoplasma-infected patients,
20 seronegative samples from healthy
donors and 10 samples from patients
suffering helminthic and other protozoal
infections. The results of Western blot
revealed that all sera from toxoplasmosis
patients reacted with the recombinant
GRA4 (Figure 4). None of the serum from
the toxoplasmosis negative control
including serum from patients suffering
helminthic and other protozoal infections
reacted with the recombinant GRA4
(Figure 4). The recombinant GRA4 identity
was further confirmed in a Western blot
probed with anti-His antibody. A single band
was present at the same position (Figure
5).
DISCUSSION
The predicted peptide size of GRA4 is
36 kDa. The protein at the downstream
region including myc epitope and the
polyhistidine-tag contribute 5 kDa to the
size of the expressed protein. Thus, the total
size of the recombinant GRA4 was
expected to be around 41 kDa. According
to previous studies, the GRA4 protein
migrates at approximately 40 to 41 kDa on
SDS-PAGE gels (Mévélec et al., 1992). A
pilot study was carried out to determine the
presence of this 40 kDa protein and its
optimal time for expression. The induction
was initially carried out with 0.5% methanol
concentration as recommended by the
Invitrogen EasySelect™ Pichia Expression
Kit Manual. SDS-PAGE gel analysis showed
a novel band at 40 kDa and the intensity of
the band was highest after 96 hours of
induction.
Another factor that affected the
expression of the recombinant GRA4 in
Pichia expression system was methanol
concentration. For the expression of protein
using AOX1 promoter, it is important to
keep the methanol level within a relatively
narrow range. High expression of foreign
protein expression depends on meticulous
control of methanol level and maintenance
529
Figure 1. SDS-PAGE analysis on the expression of recombinant GRA4 in P. pastoris. Lane M
contained the Bio-Rad Prestained Broad Range Protein Marker; Lane 1 contained supernatant of
untransformed P. pastoris X33 cell; Lane 2 contained supernatant of P. pastoris X33 cells
transformed with the pPICZα A vector alone; Lane 3-7 contained supernatant of P. pastoris X33
cells transformed with recombinant pPICZα A-GRA4 plasmid at 0 hours, 24 hours, 48 hours, 72
hours and 96 hours respectively. All samples shown were induced with 0.5% methanol. Supernatant
of protein from recombinant GRA4 P. pastoris cell showed the appearance of a novel 40 kDa
protein post induction, and its intensity peaked after 96 hours
Figure 2. SDS-PAGE analysis of the effect of various methanol concentrations on
the induction of protein expression of the transformed P. pastoris X33 cells
containing the recombinant pPICZα A-GRA4 plasmid. All samples shown were
collected after 96 hours of induction. Lane M contained the Bio-Rad Prestained
Broad Range Protein Marker; Lanes 1-5 contained the recombinant GRA induced
by a methanol concentration of 0.25%, 0.5%, 0.75%, 1% and 1.5% respectively. While
all bands were seen to become more intense with increasing concentration of
methanol, the 40 kDa band appeared as maximum intensity with 0.75% methanol
concentration (lane 3)
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Figure 4. Western blot analysis of recombinant GRA4 probed with human serum of toxoplasmosis
positive and toxoplasmosis negative control. Lane M contained the Bio-Rad Prestained Broad
Range Protein Marker. All lanes contained supernatant of P. pastoris X33 cells transformed with
recombinant pPICZα A-GRA4 plasmid. Lane 1 to 5 represents results of 5 sera of toxoplasmosis
positive patients. Lanes 6-10 represents results of sera of healthy donors, amebiasis patient,
cysticercosis patient, filariasis patient and malaria patient respectively.  It was observed that the
novel 40 kDa band was only present on the lanes probed with sera of toxoplasmosis positive
patients
Figure 3. Western blot analysis of the recombinant GRA probed with human
toxoplasmosis positive serum (IgM and IgG positive). Bound antibodies were
detected with alkaline phosphatase-conjugated goat anti-human IgM/IgG. Lane M
contained the Bio-Rad Prestained Broad Range Protein Marker; Lane 1 contained
supernatant of P. pastoris X33 cell; Lane 2 contained supernatant of P. pastoris
X33 cells transformed with the pPICZα A vector alone; Lane 3-7 contained
supernatant of P. pastoris X33 cells transformed with recombinant pPICZα A-GRA4
plasmid at 0 hours, 24 hours, 48 hours, 72 hours and 96 hours respectively. It was
observed that the novel 40 kDa band was only present on the lanes containing the
recombinant GRA4
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of dissolved oxygen in the growth medium.
Excess methanol can be toxic to the cell
and drastically reduce promoter AOX
activity, which may lead to cell death
(Brierley et al., 1990; Chiruvolu et al.,
1997; Minning et al., 2001). In addition,
methanol metabolism requires a high
concentration of oxygen and recombinant
gene expression is negatively affected by
limiting oxygen (Chen et al., 1997). In this
study, different volumes of pure methanol
were added to the media daily in order to
maintain induction of the AOX1 promoter.
A methanol feeding of 0.75% was optimal
for yeast growth and expression of GRA4.
Slightly reduced growth and expression
were observed when methanol feeding of
0.75% was used. This might probably be
due to the limited carbon or the toxic effect
of accumulated methanol.
Detection of specific antibodies is the
method of choice to diagnose toxo-
plasmosis. The recombinant proteins were
preliminary analyzed in Western blot with
the serum of a confirmed toxoplasmosis
patient. The 40 kDa recombinant protein
was found to display antigenic reactivity in
the Western blot. To further evaluate the
usage of recombinant GRA4 as immuno-
reagents in Western blot for toxoplasmosis
serology, positive and negative human sera
were reacted against the recombinant
GRA4 in Western blot. The results obtained
show that the recombinant GRA4 could
differentiate very clearly positive from
negative sera. All Western blots using
Toxoplasma-infected patient serum
detected a specific band at approximately
40 kDa. The specificity of the recombinant
protein as immunodiagnostic antigen was
also evaluated by testing against serum
from patients suffering helminthic and other
protozoal infections. The recombinant
GRA4 did not react with any of these
serum samples, demonstrating that the
recombinant antigen is specific for T.
gondii. These results suggest that the
recombinant GRA4 not only could detect
Figure 5. Western blot analysis of the recombinant GRA probed with anti-
His antibody. Lanes 1 and 2 showed distinct bands at approximately 40
kDa, after 96 hours of induction with 0.5% methanol, representing the
recombinant GRA which was expressed with a His tag tail. Lanes 3 and 4
represented supernatant of untransformed X33 cells and X33 cells
transformed with the pPICZα A vector alone respectively. Neither lane
showed any positive band for anti-His. Lane M contained the Prestained
Broad Range Protein Marker (Bio-Rad)
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antibodies against T. gondii, but also could
distinguish between toxoplasmosis and
other infections.
Recombinant expression permits the
protein to be tagged, e.g. by a polyhistidine-
tag, to facilitate purification, which means
that the purification can be done in fewer
steps. Polyhistidine-tag affinity purification
is often used for affinity purification of
polyhistidine-tagged recombinant proteins.
In this study, polyhistidine-tag was
incorporated at the C-terminal of the
recombinant protein. Thus, the recombinant
protein could easily be detected using anti-
His antibody. In the current study, the
Western blot performed using the anti-His
antibody indicated a clear band at 40 kDa.
This showed that the His-tag was intact and
in frame with the recombinant GRA4
protein, and can thus be used to purify the
protein in the future by affinity media
contain bound metal ions, either nickel or
cobalt to which the polyhistidine-tag binds
with micromolar affinity.
In conclusion, the recombinant GRA4
was successfully expressed in P. pastoris
under controlled conditions. The putative
GRA4 protein was able to detect
toxoplasmosis that could prove to be
valuable in diagnostic applications or
vaccine development. Optimizing the other
conditions such as pH, culture speed and
culture medium is expected to give a better
yield of the recombinant antigen. Our next
step will be to produce the recombinant
protein under a control environment such
as fermentor and purify the recombinant
protein by polyhistidine-tag purification
method.
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